ARROWHEAD PHARMACEUTICALS, INC. Property, Plant and Equipment, Gross
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) had Property, Plant and Equipment, Gross of $470.54 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-04
- 2026-06-30: Property, Plant and Equipment, Gross $470.54M.
- 2026-03-31: Property, Plant and Equipment, Gross $466.11M.
- 2025-12-31: Property, Plant and Equipment, Gross $464.73M.
- 2025-09-30: Property, Plant and Equipment, Gross $462.68M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2026-06-30 | $470.54M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $466.11M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $464.73M 10-Q · filed 2026-02-05 | |
| 2025-09-30 | $462.68M 10-Q · filed 2026-08-04 | |
| 2025-06-30 | $455.28M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $453.23M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $449.88M 10-Q · filed 2025-02-10 | |
| 2024-09-30 | $444.05M 10-K · filed 2025-11-25 | |
| 2024-06-30 | $429.81M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $409.22M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $379.20M 10-Q · filed 2024-02-06 | |
| 2023-09-30 | $332.21M 10-K · filed 2024-11-26 | |
| 2023-06-30 | $270.29M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $221.30M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $181.15M 10-Q · filed 2023-02-06 | |
| 2022-09-30 | $141.85M 10-K · filed 2023-11-29 | |
| 2022-06-30 | $101.24M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $82.07M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $77.32M 10-Q · filed 2022-02-02 | |
| 2021-09-30 | $71.54M 10-K · filed 2022-11-28 | |
| 2021-06-30 | $68.58M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $58.62M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $51.46M 10-Q · filed 2021-02-04 | |
| 2020-09-30 | $47.19M 10-K · filed 2021-11-22 | $47.19M 10-K · filed 2020-11-23 |
| 2020-06-30 | $45.35M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $43.22M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $39.34M 10-Q · filed 2020-02-05 | |
| 2019-09-30 | $35.30M 10-K · filed 2020-11-23 | |
| 2019-06-30 | $28.50M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $24.22M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $24.45M 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $23.74M 10-K · filed 2019-11-25 | |
| 2018-06-30 | $23.30M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $23.12M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $22.74M 10-Q · filed 2018-02-09 | |
| 2017-09-30 | $22.60M 10-K · filed 2018-12-11 | |
| 2017-06-30 | $22.49M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $21.34M 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $21.44M 10-Q · filed 2017-02-06 | |
| 2016-09-30 | $19.90M 10-K · filed 2017-12-12 | |
| 2016-06-30 | $18.86M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $10.57M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $10.47M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $9.99M 10-K · filed 2016-12-14 | |
| 2015-06-30 | $9.15M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $8.87M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $8.57M 10-Q · filed 2015-02-09 | |
| 2014-09-30 | $8.06M 10-K · filed 2015-12-14 | |
| 2014-06-30 | $7.61M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $6.96M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $6.46M 10-Q · filed 2014-02-04 | |
| 2013-09-30 | $6.59M 10-K · filed 2014-11-25 | |
| 2013-06-30 | $6.49M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $6.33M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $6.37M 10-Q · filed 2013-02-13 | |
| 2012-09-30 | $6.46M 10-K · filed 2013-12-18 | |
| 2012-06-30 | $6.79M 10-Q · filed 2012-08-13 | |
| 2012-03-31 | $7.82M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $7.65M 10-Q · filed 2012-02-09 | |
| 2011-09-30 | $365.80K 10-K · filed 2012-12-28 | |
| 2011-06-30 | $365.80K 10-Q · filed 2011-08-08 | |
| 2010-09-30 | $1.32M 10-K · filed 2011-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |